Acadia Healthcare Q1 EPS Plunges 44% to $0.05 Despite Revenue Growth
ACHC has more than doubled off its 52-week low of $11.43.
Summary
Acadia Healthcare reported first-quarter 2026 diluted EPS of $0.05, marking a significant 44.4% decline year-over-year, despite a 7.6% increase in revenue to $828.8 million. Net income attributable to the company also fell 51% to $4.11 million. This detailed 10-Q summary follows earlier news and an 8-K filing on April 29th that characterized first-quarter results as "robust" and "strong," focusing on revenue and adjusted EBITDA. The substantial drop in GAAP EPS presents a more nuanced and concerning profitability picture than previously highlighted, attributed partly to rising professional and operating costs. This could lead to negative investor sentiment as the full financial picture becomes clearer. Investors will be closely monitoring future earnings calls for management's strategy to address cost pressures and improve bottom-line performance, especially given the shift towards Medicaid in the payor mix.
At the time of this announcement, ACHC was trading at $26.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $11.43 to $28.57. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.